CVE-2023-37411 — MEDIUM (4.8)

Q: How severe is CVE-2023-37411?

CVE-2023-37411 has been rated MEDIUM with a CVSS base score of 4.8/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2023-37411?

Check the references section above for vendor advisories and patch information. Affected products include: Ibm Aspera Faspex.

Vulnerability Description

IBM Aspera Faspex 5.0.0 through 5.0.6 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 260139.

CVSS Score

4.8

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

HIGH

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Ibm	Aspera Faspex	>= 5.0.0, <= 5.0.6

Related Weaknesses (CWE)

CWE-79

References

https://exchange.xforce.ibmcloud.com/vulnerabilities/260139Vendor Advisory
https://www.ibm.com/support/pages/node/7154977Vendor Advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/260139Vendor Advisory
https://www.ibm.com/support/pages/node/7154977Vendor Advisory

FAQ

What is CVE-2023-37411?

CVE-2023-37411 is a vulnerability with a CVSS score of 4.8 (MEDIUM). IBM Aspera Faspex 5.0.0 through 5.0.6 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality p...

How severe is CVE-2023-37411?

CVE-2023-37411 has been rated MEDIUM with a CVSS base score of 4.8/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-37411?

Check the references section above for vendor advisories and patch information. Affected products include: Ibm Aspera Faspex.